HC Wainwright & Co. Maintains Fulcrum Therapeutics (FULC) Neutral Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on May 16, 2023, HC Wainwright & Co. maintained coverage of Fulcrum Therapeutics (NASDAQ:FULC) with a Neutral recommendation.
